CORONARY HEART DISEASE

This pilot study tested whether varenicline (Chantix) helps smokers with coronary heart disease quit better than the standard nicotine patch. Fifty motivated smokers who had a heart-related event were randomly assigned to one of the two treatments for 12 weeks. The main goal was …

This study looked at over 5,500 heart patients in Korea who had a drug-coated stent and took two blood thinners for about a year. After that, they were given either clopidogrel or aspirin alone for up to two more years. The goal was to see which drug better prevents heart attacks…

This study tested two experimental drugs, DFV890 (a daily pill) and MAS825 (a single shot), in 31 adults with coronary heart disease and a blood condition called CHIP. The goal was to see if these drugs could reduce specific markers of inflammation linked to heart risk. The trial…

This study tested an experimental daily pill called DFV890 in 24 adults with coronary heart disease and high levels of inflammation (measured by hsCRP). The goal was to see if the drug could safely lower certain inflammatory markers linked to heart risk. Participants took the pil…

This study looked at whether a drug-coated balloon (DCB) can safely treat blocked heart arteries, possibly avoiding the need for a permanent stent. Researchers followed 2487 patients who received the balloon instead of a stent. The goal was to see how well the balloon prevents he…

This study looked at whether adding a traditional Chinese herbal powder called Yixin Powder to standard heart medications helps people with stable angina (chest pain) from coronary heart disease. 70 adults aged 40-70 with a specific Chinese medicine pattern took part. The goal wa…

This study tested a program to help people with heart disease, stroke, or heart failure in India. The program used non-physician health workers, text messages about healthy living, and a computer tool to help doctors make decisions. 410 adults took part to see if the program impr…

This study tested a transitional care model for 108 patients with coronary heart disease who had a stent procedure. The program used structured follow-up and WeChat-based education to help patients take their medications correctly and improve self-care. Researchers measured medic…

This early-stage study tested the safety of Atorvo+™, a new drug that combines the common cholesterol-lowering medication atorvastatin with cannabidiol (CBD). The trial involved 24 healthy adults aged 40-75 to see how the body processes the drug and if it causes any side effects.…

This study tested whether an artificial intelligence (AI)-enhanced mobile app can help people with coronary heart disease manage their health after leaving the hospital. Over 1,100 participants used the app to track health metrics, receive medication reminders, and get lifestyle …

This study tested whether Yangxinshi pills, a traditional Chinese medicine, can improve exercise tolerance in people who recently had a heart stent (PCI). Over 600 participants received either Yangxinshi or the drug Trimetazidine for comparison. The main goal was to see if Yangxi…

This trial tests whether a 12-week program led by a heart health educator can lower cholesterol and improve heart health in spouses, siblings, and children of people hospitalized with coronary heart disease. Participants work with an educator to create a personal plan for smoking…

This study tested whether adding mindfulness-based stress reduction (MBSR) to aerobic exercise helps heart patients who recently had a stent procedure. 150 participants were split into two groups: one did only aerobic training, the other added daily mindfulness sessions. Research…

This study looked at how two types of drug-coated heart stents (Orsiro and Resolute Integrity) heal inside the arteries of 50 people with stable heart disease. Researchers used a special camera to check the healing 4 months after the stents were placed. The goal was to see if one…

This study tested whether specially designed educational videos, sent through a mobile messaging app, could help people with coronary heart disease improve their fitness and heart health knowledge during a 12-week home-based cardiac rehabilitation program. Twenty-one participants…

This study tested how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or diabetes. 178 adults in Leicester, UK used the app for 12 weeks to track their walking and get air quality updates. The main goal was to meas…

This study tested whether a 12-week mobile app program for heart rehab is practical and liked by patients with coronary heart disease. 34 adults used the app after leaving the hospital, and researchers tracked how many signed up, used the app, and stayed in the program. The goal …

This study reviewed records of 65 heart disease patients who completed a structured exercise program. Researchers compared their fitness, depression levels, quality of life, and sleep quality before and after rehab. The goal was to see if the program helped improve these areas. B…

This completed study looked at 175 people with both coronary heart disease and depression. Researchers measured depression severity and heart risk markers to understand which symptoms, like fatigue and loss of interest, might be linked to worse heart outcomes. The goal is to find…

This study tested an indoor air pollution intervention called AIRWISE in 20 adults aged 55 and older with heart disease. Participants received personal air cleaners, a color-changing air quality monitor, and educational materials. The goal was to see if they would use these tools…